Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Origin recognition complex subunit 2 (ORC2) is one of the six subunits of the highly conserved origin recognition complex (ORC), which is essential for the initiation of DNA replication in eukaryotes. ORC2 helps ORC bind to replication origins in an ATP-dependent manner and serves as a platform for the assembly of additional initiation factors such as Cdc6 and the MCM helicase complex[1][3][5]. ORC2 is also implicated in non-replicative functions, including heterochromatin formation, maintenance of centromeric histone methylation, chromosome segregation, centrosome duplication, and mRNA nuclear export[5]. Mutations in ORC2 can cause microcephalic primordial dwarfism (Meier-Gorlin syndrome) and are associated with certain immunodeficiency syndromes[2][3]. Currently, ORC2 itself is not targeted by approved or experimental drugs and is not considered a drug target or receptor, although disruption can affect pathways commonly altered in cancer and developmental disease[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Origin recognition complex subunit 2 (ORC2).